Stryker acquires U-M arterial disease treatment startup for $835 million
AI Summary
Stryker's acquisition of Amplitude Vascular Systems from the University of Michigan for $835 million marks a significant leap in medical technology for treating arterial disease. This move gives Stryker access to cutting-edge AVS technology that could revolutionize how such conditions are managed and treated. The acquisition underscores the growing importance of innovation in medical tech and the potential for significant advancements in patient care, reflecting Stryker's commitment to leading in medical solutions.
Original Source
Read the full article at Concentratemedia →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.